Skip to main content
OpenTrials
Completed

NCT Number: NCT01709955

The Effects of Glucomannan on Weight Loss

The purpose of this study is to determine if the herb, Glucomannan, is an effective non-pharmacological appetite suppressant for overweight or Class I obese patients. The study design will not include any other lifestyle changes which enhance weight loss in order to completely isolate the effects of Glucomannan as a non-pharmacological appetite suppressant.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

21 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects will be recruited based upon the category of them wanting to lose 50 pounds.

Subjects must be able to swallow the capsule whole with water.

Exclusion criteria

  • Self-reported use of prescription medication other than hormonal birth control (such as medication for diabetes, hypertension hypothyroidism, heart disease, cancer, etc.)
  • Pregnancy
  • Age younger than 21 or older than 60 years of age.
  • Screening for hypertension during the first laboratory visit that reveals a systole greater than 120 and a diastole greater than 90.
  • BMI calculations based upon height and weight measurements at the first laboratory visit that reveal a BMI less than 25 or greater than 35.
  • Self-reported iron-deficiency anemia, osteoporosis, and hypoglycemia.

Treatment and study plan

glucomannan

Dietary Supplement

750 MG of Glucomannan in capsule form

Placebo

Other

750 mg of Cellulose powder in a capsule form

Primary outcomes

  1. Weight Loss

    Time frame: 30 Days

Sponsors and collaborators

Lead sponsor

Northeast College of Health Sciences

Other

Registry information

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Oct 18, 2012
Registry last updated
Oct 18, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.